Breathing New Life into Immunisation Policies: Enhancing Prevention of RSV and Pneumococcal Disease 18/07/2025 Robert Cohen & Susan Hepworth Despite major breakthroughs in identifying and combating respiratory diseases, two of the most prevalent – respiratory syncytial virus (RSV) and pneumococcal disease – continue to pose a significant health burden globally, particularly in infants, young children, and older adults. Against this backdrop, a recent panel at the European Society for Paediatric Infectious Diseases (ESPID) meeting, […] Continue reading -> Health Systems Need to Use the New Tools to Address RSV, a Leading Cause of Baby Hospitalisations 02/12/2024 Susan Hepworth & Leyla Kragten-Tabatabaie From being a largely unknown pathogen, Respiratory Syncytial Virus (RSV) is now almost a household word – and a fearful one for families with infants and young children at risk. But new solutions, such as long-acting monoclonal antibodies (mAbs) and maternal vaccination, both recently recommended by the World Health Organization (WHO), could dramatically alter the […] Continue reading ->
Health Systems Need to Use the New Tools to Address RSV, a Leading Cause of Baby Hospitalisations 02/12/2024 Susan Hepworth & Leyla Kragten-Tabatabaie From being a largely unknown pathogen, Respiratory Syncytial Virus (RSV) is now almost a household word – and a fearful one for families with infants and young children at risk. But new solutions, such as long-acting monoclonal antibodies (mAbs) and maternal vaccination, both recently recommended by the World Health Organization (WHO), could dramatically alter the […] Continue reading ->